Cancer of Unknown Primary Site Active Not Recruiting Phase 2 Trials for Pembrolizumab (DB09037)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0089665 (Cancer of Unknown Primary Site) | Active Not Recruiting | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03752333 | Trial of Pembrolizumab in Cancer of Unknown Primary | Treatment |